Long-term Effects of Arteriovenous Fistula Closure on Echocardiographic Functional and Structural Findings in Hemodialysis Patients: A Prospective Study

American Journal of Kidney Diseases

Volumn 55, Issue 4, 2010, Pages 682-689

  Movilli, Ezio ^a   Viola, Battista Fabio ^a   Brunori, Giuliano ^b   Gaggia, Paola ^a   Camerini, Corrado ^a   Zubani, Roberto ^a   Berlinghieri, Nicola ^a   Cancarini, Giovanni ^a  

^a SPEDALI CIVILI   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Arteriovenous fistula; cardiac remodelling; hemodialysis; left ventricular hypertrophy

Indexed keywords

ADULT; AGED; ARTERIOVENOUS SHUNT; ARTERIOVENOUS SHUNT CLOSURE; ARTICLE; CARDIOVASCULAR PARAMETERS; CENTRAL VENOUS CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC POSTERIOR WALL THICKNESS; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE INTERNAL DIASTOLIC DIAMETER; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE MASS INDEX; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM THICKNESS; HEMODIALYSIS PATIENT; HUMAN; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; TISSUE STRUCTURE; VASCULAR ACCESS;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 77949571582     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.11.008     Document Type: Article

References (21)

1. MacRae J.M., Levin A., and Belenkie I. The cardiovascular effects of arteriovenous fistulas in chronic kidney disease: a cause for concern?. Semin Dial. 19 (2006) 349-352
2. Canaud B., and Krieter D.H. High-flux renal replacement therapies. In: Nissenson A.R., and Fine R.N. (Eds). Clinical Dialysis. 4th ed. (2005), McGraw-Hill Companies, New York 949-962
3. Unger P., and Wissing K.M. Arteriovenous fistula after transplantation: utility, futility or threat?. Nephrol Dial Transplant. 21 (2006) 254-257
4. Bossola M., Tazza L., Vulpio C., and Luciani G. Is regression of left ventricular hypertrophy in hemodialysis patients possible?. Semin Dial. 21 (2008) 422-430
5. Daugirdas J.T. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 4 (1993) 1205-1213
6. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2 (1989) 358-367
7. Ganau A., Devereux E.B., Roman J.M., et al. Patterns of left ventricular hypertrophy and geometry remodelling in essential hypertension. J Am Coll Cardiol. 19 (1992) 1550-1558
8. Levi D., Savage D.D., Garrison R.J., Anderson K.M., Kannel W.B., and Castelli W.P. Echocardiographic criteria for the left ventricular hypertrophy: the Framingham Study. Am J Cardiol. 59 (1987) 956-960
9. Harnett J.D., Kent G.M., Barre P.E., Taylor R., and Parfrey P.S. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol. 4 (1994) 1486-1490
10. Muiesan M.L., Salvetti M., Rizzoni D., Castellano M., Donato F., and Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long term antihypertensive treatment. J Hypertens. 13 (1995) 1091-1095
11. Cannella G., La Canna S., Sandrini M., et al. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant. 6 (1991) 31-37
12. Meeus F., Kourilsky O., Guerin A.P., Gaudry C., Marchais S.J., and London G.M. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl. 76 (2000) S140-S147
13. Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 11 (2007) 21-31
14. Alpert M.A. Cardiac performance and morphology in end-stage renal disease. Am J Med Sci. 325 (2003) 168-178
15. London G.M. Left ventricular hypertrophy: why does it happen?. Nephrol Dial Transplant. 18 suppl 8 (2003) 2-6
16. Burrows L., and Muller R. Chronic kidney disease and cardiovascular disease: pathophysiologic links. Nephrol Nurs J 34 (2007) 55-63
17. Portolés J., Torralbo A., Martin P., Rodrigo J., Herrero J.A., and Barrientos A. Cardiovascular effects of recombinant human erythropoietin in pre dialysis patients. Am J Kidney Dis. 29 (1997) 541-548
18. Bárány P., and Müller H.J. Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease. Nephrol Dial Transplant. 22 suppl 4 (2007) 10-18
19. Basile C., Lomonte C., Vernaglione L., Casucci F., Antonelli M., and Losurdo N. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant. 23 (2008) 282-287
20. Berkoben M.S., and Schwab S.J. Vascular access for hemodialysis. In: Nissensson A., and Fine R.N. (Eds). Clinical Dialysis. 4th edition (2005), McGraw-Hill Companies, New York 27-45
21. National Kidney Foundation. K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Vascular Access 2006. Am J Kidney Dis. 48 suppl 1 (2006) S176-S322